An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Arcus Biosciences (NYSE:RCUS) announced its participation in key investor conferences. The Citi 17th Annual BioPharma Conference will take place on September 7, 2022, in Boston, MA, featuring 1-on-1 meetings. Following this, the Morgan Stanley 20th Annual Global Healthcare Conference is scheduled for September 12, 2022, in New York, NY, with a fireside chat at 12:30 p.m. ET. A live webcast will be available on the Arcus website, with replays accessible afterward.
Positive
None.
Negative
None.
HAYWARD, Calif.--(BUSINESS WIRE)--
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences:
Citi 17th Annual BioPharma Conference Date:Wednesday, September 7th, 2022
Location:Boston, MA Format: 1-on-1 meetings only
Morgan Stanley 20th Annual Global Healthcare Conference
Date:Monday, September 12th , 2022 at 12:30 p.m. ET Location:New York, NY Format: Fireside Chat
A live webcast of the fireside chat will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. A replay of the webcast will be available following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biological targets and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b receptor) and most recently, HIF-2a. For more information about Arcus Biosciences’ clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.
Media Inquiries
Holli Kolkey VP of Corporate Communications
(650) 922-1269
hkolkey@arcusbio.com
Investor Inquiries
Pia Banerjee Head of Investor Relations & Strategy
(617) 459-2006
pbanerjee@arcusbio.com
Source: Arcus Biosciences
FAQ
What investor conferences will Arcus Biosciences participate in September 2022?
Arcus Biosciences will participate in the Citi 17th Annual BioPharma Conference on September 7, 2022, and the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022.
When is the Citi 17th Annual BioPharma Conference scheduled?
The Citi 17th Annual BioPharma Conference is scheduled for September 7, 2022.
What format will the Morgan Stanley Global Healthcare Conference take?
The Morgan Stanley Global Healthcare Conference will feature a fireside chat.
Where can I watch the Arcus Biosciences fireside chat?
The fireside chat from Arcus Biosciences can be viewed live on their website in the 'Investors & Media' section.
